Arthur H. Spiegel III insider trades: Accretive Health (AH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Arthur reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 17, 2011 | AH | ↓ Sell | 141,931 | $28.63 | $4.1M | Direct | Aug 18, 2011 (1d) |
| Mar 30, 2011 | AH | ↓ Sell | 198,842 | $22.44 | $4.5M | By Spiegel Family LLC | Apr 1, 2011 (2d) |
| May 25, 2010 | AH | ↓ Sell | 196,320 | $11.28 | $2.2M | By Spiegel Family LLC | May 27, 2010 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Arthur H. Spiegel III's insider trades
Arthur H. Spiegel III is a director at Accretive Health (AH). Since May 25, 2010, Arthur has reported no open-market purchases and 3 sales worth $10.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (18 filings), conversions (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.